PHILADELPHIA — The Arthritis Foundation recently presented the Sir John Charnley, MD, Award to L. Scott Levin, MD, FACS, chair of the Department of Orthopaedic Surgery, the Paul B. Magnuson Professor of Bone and Joint Surgery, and professor of Surgery (Division of Plastic Surgery) in the Perelman School of Medicine at the University of Pennsylvania. Dr. Levin is an internationally recognized orthopaedic surgeon who has dedicated his career to the care of thousands of patients and to the improvement of hand, wrist and hip disorders.

“Sir John Charnley was a visionary in the field of Orthopaedics, and I am pleased to receive an award named in his honor,” said Dr. Levin. “Continued collaboration with colleagues and groups like the Arthritis Foundation is vital to advancing the latest techniques in Orthopaedic care. Working with the Foundation has been a great way to give back to the field, advocate to the public about the options available in musculoskeletal care, and promote groundbreaking research.”

Sir John Charnley, MD, was an orthopaedic surgeon who in 1962 invented the modern hip replacement. He was a master surgeon, innovator and bio-engineer. Today, Dr. Charnley is recognized as one of the fathers of modern Orthopedics.

Presented annually at the Arthritis Foundation, Eastern Pennsylvania Chapter’s Evening of Honors gala, the Sir John Charnley, MD, Award recognizes the important role of a doctor in the field of orthopaedics who dedicates themselves to improving the world around them, particularly in the Philadelphia community.

Dr. Levin is Board-certified in Orthopedic Surgery and has a Certificate of added Qualification in hand surgery.  In addition, he is Board-certified in Plastic and Reconstructive Surgery. As an accomplished clinician, his expertise focuses on surgery of the hand and upper extremity, reconstructive microsurgical techniques for extremity reconstruction and limb salvage. His research interests focus predominantly on extremity soft tissue reconstruction and vascularized composite allotransplantation.

The Arthritis Foundation is the largest national nonprofit organization that supports the more than 100 types of arthritis and related conditions.  With multiple service points located throughout the country, the Arthritis Foundation is the largest private, nonprofit contributor to arthritis research in the world, funding more than $450 million in research grants since its founding in 1948.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.

Share This Page: